About This Calculator

This Blenrep (belantamab mafodotin) Dosing Calculator is designed to assist healthcare professionals in determining the appropriate dose and vial preparation based on patient weight. It is intended for educational and informational purposes and should not replace clinical judgment or the full Prescribing Information.

Outputs

The calculator provides the following key outputs for safe and accurate administration:

• Total Calculated Dose (mg): The precise dose of belantamab mafodotin for the patient, calculated from their weight and the selected dose level.
• Number of Vials Needed: The total number of 100 mg vials required for reconstitution. This is rounded up to the nearest whole vial.
• Volume to Withdraw (mL): The total volume of reconstituted solution (at 20 mg/mL) to be withdrawn from the vial(s) for admixture.
• Amount to be Discarded (mg): The quantity of drug remaining in the final vial that should be discarded.

How to Use

To use the calculator, a healthcare professional must provide the following inputs:

1. Patient Weight: Enter the patient's current body weight. The calculator accepts weight in both kilograms (kg) and pounds (lbs) and will perform the necessary conversion.
2. Dosing Regimen: Select the appropriate dose level from the dropdown menu, which includes the standard 2.5 mg/kg dose and the first dose reduction level of 1.9 mg/kg.

Dosing Overview

Blenrep is administered as an intravenous infusion every 3 weeks. The dose is calculated based on the patient's actual body weight. The recommended dosing schedule is as follows:

Dose modifications, including delays and reductions, are required for management of adverse reactions, particularly ocular toxicity.

Switching

This calculator does not provide guidance on switching from or to other therapies. Decisions regarding treatment sequencing for patients with multiple myeloma should be based on clinical evaluation, prior therapies, and current treatment guidelines. Always consult the full Prescribing Information for details on Blenrep's place in therapy.

Missed Dose

If a planned dose of Blenrep is missed, it should be administered as soon as possible, and the schedule should be adjusted to maintain a 3-week interval between doses. Consult the Prescribing Information for specific guidance on treatment delays.

Safety Alerts

Blenrep has a BOXED WARNING for Ocular Toxicity. It can cause severe ocular adverse reactions, including keratopathy, changes in visual acuity, severe vision loss, and corneal ulcer. Due to these risks, Blenrep is only available through a restricted Risk Evaluation and Mitigation Strategy (REMS) program. Other significant warnings include thrombocytopenia and infusion-related reactions. Refer to the full Prescribing Information for complete safety information.

Frequently Asked Questions (FAQ)

• What vial size does the calculator use?
  The calculation assumes the use of 100 mg single-dose vials of Blenrep.
• How does the calculator handle weight conversion?
  If weight is entered in pounds (lbs), the calculator automatically converts it to kilograms (kg) using the conversion factor of 1 lb = 0.453592 kg before calculating the dose.
• Does the calculator account for dose capping?
  The Prescribing Information does not specify a maximum dose or a dose cap. The dose is calculated based on the patient's actual body weight.
• Can I use this for the second dose reduction?
  No. The calculator only provides options for the standard dose and the first dose reduction. According to the dosing schedule, a second dose reduction requires permanent discontinuation of treatment.
• Why is the "Volume to Withdraw" calculated?
  The calculator determines this volume based on the final concentration of the reconstituted drug, which is 20 mg/mL (100 mg vial reconstituted with 5.2 mL of SWFI).
• Is this tool a substitute for the BLENREP REMS program?
  Absolutely not. This tool is for dose calculation only. All healthcare professionals who prescribe or dispense Blenrep must be certified in the BLENREP REMS program.
• What should I do if a patient's weight is very high or low?
  The tool will calculate the dose based on the weight entered. However, for patients at extremes of weight, it is crucial to exercise clinical judgment and verify the calculated dose.
• Does this calculator consider renal or hepatic impairment?
  No, the calculator does not have inputs for renal or hepatic function. Refer to the Prescribing Information for specific dose adjustment recommendations in these populations.

References

• BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use - Full Prescribing Information. U.S. Food and Drug Administration.
• Blenrep HCP Official Website. GlaxoSmithKline.
• BLENREP REMS Program Website.
• Blenrep (belantamab mafodotin) European Medicines Agency Summary of Product Characteristics.